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Abstract.  INO (inhibitor of neurite outgrowth) is a 
monoclonal antibody that blocks axon outgrowth, 
presumably by functionally blocking a  laminin-hepa- 
ran sulfate proteoglycan complex (Chiu, A.  Y., W.  D. 
Matthew, and P.  H.  Patterson.  1986. J.  Cell Biol. 
103:1382-1398).  Here the effect of this antibody on 
avian neural crest cells was examined by microinject- 
ing INO onto the pathways of cranial neural crest 
migration. After injection lateral to the mesencephalic 
neural tube, the antibody had a  primarily unilateral 
distribution. INO binding was observed in the basal 
laminae surrounding the neural tube, ectoderm, and 
endoderm, as well as within the cranial mesenchyme 
on the injected side of the embryo. This staining pat- 
tern was indistinguishable from those observed with 
antibodies against laminin or heparan sulfate pro- 
teoglycan. The injected antibody remained detectable 
for 18 h after injection, with the intensity of immuno- 
reactivity decreasing with time.  Embryos ranging from 
the neural fold stage to the 9-somite stage were in- 
jected with INO and subsequently allowed to survive 
for up to  1 d  after injection. These embryos demon- 
strated severe abnormalities in cranial neural crest 
migration.  The predominant defects were ectopic neu- 
ral crest cells external to the neural tube, neural crest 
cells within the lumen of the neural tube, and neural 
tube deformities. In contrast, embryos injected with 
antibodies against laminin or heparan sulfate pro- 
teoglycan were unaffected. When embryos with ten or 
more somites were injected with INO,  no effects were 
noted, suggesting that embryos are sensitive for only a 
limited time during their development. Immunoprecip- 
itation of the INO antigen from 2-d chicken embryos 
revealed a  200-kD  band characteristic of laminin and 
two broad smears between 180 and 85 kD,  which were 
resolved into several bands at lower molecular mass 
after heparinase digestion. These results indicate that 
INO precipitates both laminin and proteoglycans bear- 
ing heparan sulfate residues.  Thus,  microinjection of 
INO causes functional blockage of a  laminin-heparan 
sulfate proteoglycan complex, resulting in abnormal 
cranial neural crest migration. This is the first evi- 
dence that a  laminin-heparan sulfate proteoglycan 
complex is involved in aspects of neural crest migra- 
tion in vivo. 
N 
'EURAL crest cells are a highly migratory population 
of cells that give rise to a variety of derivatives in- 
cluding neurons and Schwann cells of the peripheral 
nervous system, pigment cells, adrenomedullary cells, and 
some skeletal and connective tissue (19). The mechanisms 
underlying the migration and differentiation of this popula- 
tion have been the focus of numerous recent experiments. 
The role of the extracellular matrix (ECM) ~ in the process 
of neural crest cell movement has been of particular interest, 
since  ECM  molecules like  fibronectin (FN)  and  laminin 
(LM) have been found to promote neui'al crest migration in 
vitro (24,  29)  and have  been detected along neural crest 
migratory pathways in vivo (15, 23, 28).  Antibodies against 
the cell binding region of FN (26) and against integrin (6, 7), 
a cell surface receptor for FN and LM (12), have recently 
1.  Abbreviations  used  in  this  paper:  ECM,  extracellular  matrix;  FN, 
fibronectin; HSPG, heparan sulfate proteoglycans; INO, inhibitor of neurite 
outgrowth; LM, laminin. 
been  shown to  interfere with normal cranial neural crest 
migration. These data strongly suggest the importance of a 
functional interaction between FN and its receptor in cranial 
neural crest migration. Although laminin is present along 
neural crest pathways and has been implicated as an impor- 
tant molecule in neurite outgrowth, little is known about the 
role of laminin, if any, in neural crest migration in situ. 
Some interesting parallels between neural crest migration 
and neurite outgrowth have recently been described. Keynes 
and Stern reported that motoraxons eminating from the ven- 
tral neural tube preferentially move through the anterior half 
of each somite in the trunk of the avian embryo (14). Sub- 
sequently, it was noted that trunk neural crest cells follow 
a  spatially  and  temporally  similar  pathway  of migration 
through the anterior somite to that of the motoraxons (8, 27). 
In tissue culture, antibodies against integrin have been shown 
to disrupt both neural crest migration (6)  and neurite out- 
growth (3, 32) on fibronectin and laminin substrates. These 
￿9  The Rockefeller University Press, 0021-9525/88/04/1321/9 $2.00 
The Journal of Cell Biology, Volume 106, April 1988 1321-1329  1321 experiments  suggest  that  neural  crest  cells  and  growing 
axons both share some common cell surface receptor mole- 
cules,  responsiveness to extracellular matrix  components, 
and pathways of migration 
The role of the ECM in the outgrowth and regeneration of 
peripheral  neurites  has  been  the  subject  of many  recent 
studies in tissue culture (1,  17, 21, 30). When plated on the 
ECM deposited by a variety of different cultured cell lines, 
neurons respond rapidly with  extensive neurite outgrowth 
(21). Laminin and heparan sulfate proteoglycans are major 
components of the neurite outgrowth promoting factors pro- 
duced by various nonneuronal cells (17). In addition, purified 
laminin provides a particularly good substrate for axon out- 
growth (17, 21). However, antibodies that block neurite out- 
growth on purified laminin do not usually block outgrowth 
on the natural neurite-promoting complex (17, 21). This sug- 
gests that the active complex in naturally occurring matrices 
may contain other isoforms of laminin or laminin in which 
some epitopes are altered or masked by associated molecules 
such as heparan sulfate proteoglycan. 
Matthew and Patterson (23) have isolated the monoclonal 
antibody INO (inhibitor of neurite outgrowth) which recog- 
nizes and functionally blocks the neurite promoting complex 
in its native form, in which laminin is associated with hepa- 
ran sulfate proteoglycan. In adult rat tissues,  this complex 
was observed on the surface of glial cells in the peripheral 
but not central  nervous  system,  and  within the  basement 
membranes surrounding most tissues (8). In a recent study 
examining the distribution of laminin  and heparan  sulfate 
proteoglycans (HSPG),  we have noted that the patterns of 
LM and HSPG immunoreactivity overlap in avian embryos 
during neural crest migration (Krotoski, D.,  C.  Domingo, 
R.  Perris, and M.  Bronner-Fraser, manuscript in prepara- 
tion).  This is consistent with the notion that laminin and 
heparan sulfate proteoglycan exist as a complex in the avian 
embryo as well.  The present study examines the possible 
functional role of this laminin-heparan sulfate proteoglycan 
complex in cranial neural crest migration in situ by function- 
ally perturbing this complex using the INO antibody. 
Materials and Methods 
Monoclonal Antibodies 
INO (kindly provided by Dr. W. Matthew, Harvard University), anti-lami- 
nin, and anti-heparan sulfate proteoglycan (2;  kindly provided by Dr.  D. 
Fambrough, The Johns Hopkins University) hybridoma cells were grown 
in DME supplemented with 20% fetal calf serum and non-essential amino 
acids. Before injection, the antibody-containing culture medium superna- 
tant was concentrated 20-30-fold as described previously (6) using Amicon 
Corp., Danvers, MA, microcentricon filters which pass molecules under 30 
kD. As a control, culture medium lacking monoclonal antibodies was con- 
centrated in the manner described above and is referred to as concentrated 
medium. 
Preparation of the Embryos  for Microinjection 
White Leghorn chicken embryos were used for antibody injection. Embryos 
ranging in age from stages 8-10 according to the criteria of Hamburger and 
Hamilton (ll) were used for most experiments in which INO was injected 
into the mesencephalon. To examine the effects of INO on slightly older em- 
bryos, stage ll-13 were used. For injections into the trunk, embryos between 
stages 12 and 17 were used as hosts. The eggs were washed with 70% ethanol 
and a  window was made over the embryo. India ink (Pelikan,  Hanover, 
FRG) was injected under the blastodisc to aid in visualization. After injec- 
tion, the window over the embryo was closed with adhesive tape and the 
embryo was returned to the incubator until the time of fixation. 
Microinjection of  Antibodies into Chicken Embryos 
For  injections into the mesencephalon, concentrated  medium containing 
INO,  LM, or HSPG antibodies was injected lateral to the mesencephalic 
neural tube. The antibodies were backfilled into glass micropipettes with 
openings of 20-30-~tm diam. A micromanipulator was used to position the 
pipette tip within the mesencephalon. The antibody suspension (~4 nl  in 
volume) was expelled with a pulse of pressure and the injection micropipette 
was withdrawn. For injections into the trunk region, antibody was microin- 
jected into the somites as described previously (5).  To mark the level  of 
injection, a tungsten needle with carmine on its tip was inserted into and 
withdrawn from one somite rostral to the injected somite and on the opposite 
side of the embryo. The carmine marker remained near the injection site. 
Histology and Tissue Sectioning 
Cryostat  Sections.  Embryos  were  fixed overnight  in  methanol at  4~ 
hydrated in PBS for I h, placed in 0.5%  sucrose in PBS containing 0.01% 
azide for 2-4 h, and into 15% sucrose in PBS at 4~  overnight. They were 
then placed  in 7.5%  gelatin (Sigma Chemical Co.,  St.  Louis, MO;  300 
Bloom) and  15%  sucrose in PBS at 37~  for 2-3 h, oriented, and frozen 
in Tissue Tek OCT (Miles Laboratories, Naperville, IL) in liquid nitrogen. 
10-1xm frozen sections were cut on a Histostat cryostat (Reichardt Scientific 
Instruments, Buffalo, NY). 
Paraffin Sections.  Embryos were  fixed for  1.5  h  in Zenker's fixative, 
washed in running water,  and placed in 70%  ethanol. The embryos were 
then dehydrated and embedded in paraffin.  10-p_m serial sections were cut 
on a  Leitz microtome and mounted on albuminized slides. 
Immunofluorescent Staining 
Distribution  of the Injected  INO.  Cryostat sections from embryos fixed 
from 2-24 h after injection were stained for 1 h at room temperature with 
a highly fluorescent antibody against mouse Ig's (Antibodies, Inc., Davis, 
CA). Sections were examined on an Olympus Vanox epifluorescence micro- 
scope and data were recorded photographically. 
Identification  of Neural Crest Cells. After fixation and paraffin embed- 
ding, sections were stained with HNK-1 antibodies which serve as a marker 
Ibr  migrating neural crest cells (8,  33).  Sections were  deparaffinized in 
histosol, hydrated through a graded series of ethanols, and washed in PBS. 
They were then incubated with culture medium from HNK-1  hybridoma 
cells for 3 h at room temperature or overnight at 4~  After washing in PBS, 
slides were incubated with a  rabbit antibody that recognizes mouse lgMs 
for l  h, followed by an hour incubation with a fluorescein-conjugated goat 
antibody against rabbit IgGs. The slides were washed in PBS, coverslipped, 
and observed with  an Olympus epifluorescence microscope.  Data  were 
recorded photographically. 
Purification of  Antibodies 
INO, anti-laminin, and anti-heparan sulfate proteoglycan antibodies were 
purified from culture medium supernatant from hybridoma cells by precipi- 
tation  with  50%  ammonium sulfate.  The  sample was then centrifuged, 
resuspended in distilled water, and dialyzed against 0.1 M  PBS at 4~  for 
48 h. The dialysate was placed over a protamine-sulfate sepharose column 
and eluted with  1.1  M  NaCI/0.1  M  PBS. 
Preparation of  Small Fragments of the INO Antibody 
Small fragments of IgM antibody were prepared as described by Matthew 
and Reichardt (22).  INO was purified as described above and equilibrated 
on a P-2 column (Bio-Rad Laboratories, Richman, CA) with Tris-buffered 
saline (pH 8.0).  The void volume was collected and the concentration was 
adjusted to 1 mg/ml in Tris buffer. The whole IgMs were digested with 0.01 
mg/ml trypsin (TPCK;  Millipore Corp.,  Bedford,  MA) for 5  h  at 37~ 
B-Mercaptoethanol was then added to the mixture (final concentration of 
10 mM) for 5 min at 37~  followed by soybean trypsin inhibitor (final con- 
centration of 0.1 mg/ml) for 5 min at 25~  The small IgM fragments were 
dialyzed four times against 1 liter of 0.1 M PBS at 4~  for 48 h. Fragments 
were sized on a Biogel P-300 column and only fragments smaller than 150 kD 
were used for the microinjection experiments. Of these, 90% were 55 kD 
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NaCI,  I  mM MgClz,  1 mM CaCI2. The antigen was eluted in a  minimal 
volume of 100 mM glycine, pH 3.0, and immediately neutralized  with 2 M 
NaOH. The eluants were then concentrated using Centricon microconcentra- 
tors  (Amicon  Corp.).  A  portion  of the  INO  eluant  was  subjected  to 
heparinase digestion. Heparinase (Sigma Chemical Co.) was diluted in 50 
mM Tris, pH 7.0, containing  100 mM NaCI and 100 gtg/ml BSA, Five units 
of heparinase were added to I0 gtl of the INO eluant (1 mg/ml) and incubated 
for 5 h at 37~  (20,  31). 
Analysis of the antigens was performed using SDS-PAGE using 8 % gels 
in a vertical mini-slab gel system (Hoefer Scientific Instruments, San Fran- 
cisco, CA), with a 4% stacking gel utilizing the buffer system described by 
Laemmli (13). Polyacrylamide gels were then fixed in a solution of 10% eth- 
anol/5% acetic acid and stained using a Silver stain kit (National Diagnos- 
tics Inc., Somerville, NJ) until bands appeared within the gel. Excess sur- 
face staining was  removed using Argent=X  silver stain bleach (National 
Diagnostics). This tended to lower background and gave sharper bands on 
the gel. Antibodies against laminin and heparan sulfate proteoglycan have 
been characterized elsewhere (2). 
Figure L  Fluorescence  photomicrographs  of transverse  cryostat 
sections through the mesencephalon of chick embryos 2-3 h after 
injection of INO antibody lateral to the mesencephalic neural tube 
(NT). (a and b) INO was observed in the basement membrane sur- 
rounding the neural tube,  under the ectoderm (E) and the endo- 
derm. The INO antibody distribution was primarily unilateral, with 
little immunoreactivity  detectable across  the embryonic midline. 
(c) Higher magnification of the same embryo shown in b illustrates 
that fibrillar INO immunoreactivity was observed within the cranial 
mesenchyme (M).  INO, antibody that  inhibits neurite outgrowth. 
Bar: (a) 50 ~tm; (b) 77 grn; (c) 29 ~tm. 
or less. Thus, by virtue of  their size, 90% of  the fragments were monovalent. 
Approximately 500 lag/ml of small fragments were used for injection. 
Immunoprecipitation of the INO Antigen 
from 2-d Chicken Embryos 
Chick embryos with 10-17 somites were minced by trituration and incubated 
in INO for 2 h at 4~  The sample was then lysed using a Bronwill (Rochester, 
NY) Biosonk probe sonieator for 30-60 s. The INO samples were incubated 
with FMP-Fractogel beads (Bioprobes, Tustin,  CA) conjugated with rabbit 
anti-mouse IgM (Zymed, Berkeley, CA) for 8 h at 4~  The beads were then 
Results 
Distribution of  lNO after Injection 
INO was injected lateral to the mesencepbalic neural tube in 
embryos with up to nine somites. The distribution pattern of 
the antibody and  the  longevity of detectable immunoreac- 
tivity were determined as a function of time after injection. 
Embryos were examined from 2  to 24 h  after injection. 
At  all  times examined,  the  distribution  of antibody  ap- 
peared to be primarily unilateral,  confined to the  injected 
side.  In embryos fixed 2-3 h  after injection,  immunoreac- 
tivity was observed surrounding all basal laminae on the in- 
jected side, including the basal surface of the neural tube, ec- 
toderm, endoderm, and notochord (Fig.  1, a  and b).  Some 
immunoreactivity was noted on the ventral-most portion of 
the neural tube on the uninjected side. This indicates that a 
small amount of antibody did cross the midline. In addition 
to staining  in  basal laminae,  some INO immunoreactivity 
was noted within the cranial mesenchyme. This staining pat- 
tern was non-uniform and fibrillar in appearance (Fig.  1 c), 
suggesting that the INO was not in a  lamellar organization 
but rather in a loose matrix surrounding mesenchyme cells. 
INO immunoreactivity was detected in the prosencephalon, 
mesencephaion, and rhombencephalon, suggesting that the 
injected antibody was able to diffuse rostral and caudal to the 
site of injection. 
To compare the distribution  of INO with that of laminin 
and heparan sulfate proteoglycan, stage 8-10 embryos were 
injected with antibodies against LM or HSPG, and allowed 
to survive for 2-3 h. Like INO, the distribution of LM (Fig- 
ure 2 a) or HSPG (Fig. 2 b) was primarily unilateral. Binding 
of both antibodies was observed on the basal surface of the 
neural tube, ectoderm, endoderm, and notochord, as well as 
in  fibrils  within  the  cranial  mesenchyme.  These  patterns 
were indistinguishable from that observed for injected INO 
antibody. 
The pattern of INO immunoreactivity remained the same 
as described above in embryos fixed at progressive times af- 
ter  injection,  but  the  intensity  of  immunoreactivity  de- 
creased. By 18 h after injection, only very low levels of im- 
munoreactivity were detectable on the basal surface of the 
neural  tube,  ectoderm, and endoderm. 
The distribution and longevity of INO immunoreactivity 
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sections  through the mesencephalon of chick embryos 2-3 h after 
injection  of control antibody lateral  to the mesencephalic  neural 
tube (NT). a illustrates  the distribution  of anti-laminin antibodies 
after injection.  The distribution  is unilateral  and similar  to that of 
INO. Staining was observed around the neural tube, ectoderm, and 
endoderm, as well as within the cranial mesenchyme; (b) illustrates 
the distribution  of anti-heparan sulfate proteoglycan  antibodies  af- 
ter injection.  Staining was observed unilaterally  around the neural 
tube,  ectoderm, endoderm, and within  the cranial  mesenchyme. 
LM, anti-laminin; HSPG, anti-heparan sulfate proteoglycan. Bar, 
50 ~tm. 
was examined in embryos having 10 or more somites.  After 
injection into the mesencephalon, the pattern and persistence 
of INO staining  was  identical  to that described  above for 
younger embryos. When injected into the trunk somites, INO 
also had a primarily unilateral distribution around the neural 
tube, dermamyotome, and ectoderm. In addition, some fibril- 
lar staining was noted in the sclerotome. The pattern of dis- 
tribution was identical to that previously reported for laminin 
(15, 22). INO immunoreactivity remained detectable for ap- 
proximately  18 h  after injection of antibody into the trunk. 
Figure 3.  Fluorescence photomicrographs of transverse  paraffin 
sections through the cranial region of  embryos and fixed within the 
first day after injection.  Neural crest cells  can be recognized by 
their immunofluorescence  after staining with the HNK-I antibody. 
(a) An embryo, injected at the 6-somite stage and fixed 19 h later, 
with ectopic aggregates of neural  crest cells (indicated by arrows) 
observed bilaterally  adjacent to the neural  tube (NT). The neural 
tube was open and deformed; (b) Another embryo injected  at the 
6-somite stage and examined  20 h later.  In the rhombencephalon 
at the level of the otic vesicles (OV), an ectopie aggregate of neural 
crest cells (indicated  by the arrow) was observed adjacent to the 
neural  tube.  Bar: (a) 50 p.m; (b) 58 ~tm. 
Effects of lNO on Neural Crest Migration In Situ 
Embryos were injected with INO and allowed to survive for 
up to 24 h after injection to determine the effects of the anti- 
body on cranial neural crest migration in vivo. The results 
are summarized in Table I. 68 embryos were injected with 
the antibody. Of these 74 % had abnormalities in neural crest 
Table L Effects of  lNO, LM, and HSPG Antibodies on Cranial Neural Crest Migration  In Vivo 
Type of Antibody 
Type of defect  INO  INO fragments  Anti-LM  Anti-HSPG  Conc. medium 
Total number  68  10  39  28  34 
Percent affected  74  70  10  4  12 
Percent NC in lumen of NT  25  20  4  4  6 
Percent ectopic NC cells  40  30  0  0  6 
Percent neural tube anomalies  31  40  0  4  3 
NC, neural crest, NT, neural tube. Percentages are expressed as percent total n of embryos in each category. Some embryos had defects in more than one 
category. 
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sections through the cranial region of embryos injected with INO 
antibody and fixed within the first day after injection. Neural crest 
cells can be recognized by their immunofluorescence after staining 
with the HNK-1 antibody. (a) A section at the level of the otic vesi- 
cles  in the rhombencephalon  illustrating neural crest cells  (indi- 
cated by the arrow) which have remained within the lumen of the 
neural tube. This embryo was at the neural fold stage at the time 
of injection and was fixed 19 h later; (b) another embryo, injected 
with INO at the three-somite stage and fixed 18 h later. At the level 
of the mesencephalon,  neural crest cells (indicated by arrow) ap- 
peared to be trapped within the lumen of the neural tube; (c) an em- 
bryo injected with small INO fragments.  At the level of the otic 
vesicles, neural crest cells (indicated by the arrow) have remained 
within the neural tube.  Bar, 50 lam. 
and/or neural tube development. Although the antibody was 
injected at the level of the mesencephalon, defects were noted 
both in the mesencephalon and in the rhombencephalon. This 
is not surprising since the injected antibody diffused into the 
rhombencephalon.  The  predominant  defect  was  displaced 
aggregates of neural crest cells external to the  neural  tube, 
which will be referred to as ectopic neural crest cells, ob- 
served in 40 % of the 68 embryos injected with INO. 31% of 
the embryos had neural tube anomalies, and 25 % had neural 
crest cells within the lumen of the neural tube.  Many of the 
embryos  had  multiple  defects,  e.g.,  both  ectopic  neural 
crests and neural tube deformities (observed in  13 % of the 
embryos) or ectopic cells and cells within the lumen of the 
neural tube (6% of the embryos). This is illustrated in Fig. 
3, a and b, which shows two embryos with ectopic aggregates 
of neural crest cells external to the neural tube, as well as se- 
verely malformed neural tubes. However, the majority (70%) 
of the affected embryos had only one of the three types of 
defect. In most but not all cases, the ectopic cells were ob- 
served unilaterally on the  injected side or above the dorsal 
neural  tube in serial sections through the entire head (Fig. 
3 b). In a few cases, ectopic aggregates were seen bilaterally 
(Fig. 3 a). Other embryos had a build-up of neural crest cells 
within the lumen of the neural tube, as illustrated in Fig. 4. 
In these cases,  an aggregate of neural  crest cells could be 
seen protruding into the lumen of the neural tube. Such de- 
fects were observed at the level of the mesencephalon (Fig. 
4 b) or at the level of the otic vesicles in the rhombencepha- 
Ion (Fig. 4 a).  Although most experiments were performed 
with concentrated medium containing INO antibodies, simi- 
lar results were obtained for embryos injected with purified 
INO antibody. In contrast to a previous study in which anti- 
bodies to  integrin,  a  FN  and  LM  receptor,  were microin- 
jected into the mesencephalon (7), no apparent reduction in 
the  numbers of neural  crest cells on  the  injected  side was 
noted relative to the uninjected  side in any of the 68  INO- 
treated embryos. Since the effects of INO were sometimes 
bilateral, it remains possible that both the injected and unin- 
jected  side  were  equally  affected.  It  should  be  noted  that 
many neural crest cells in the injected embryos appeared to 
migrate normally in the presence of the INO antibody. INO 
may,  therefore,  only  affect subpopulations  of neural  crest 
cells,  or may affect cells for a  limited time. 
In another series of experiments, INO was injected into the 
trunk somites during the time of initial neural crest migration 
and motoraxon elongation. In contrast to the striking effects 
observed with cranial neural crest cells, we were unable to 
detect  defects  in  either  trunk  neural  crest  migration  or 
motoraxon outgrowth  when using either concentrated INO 
medium or  1 mg/ml of purified antibody (Fig.  5). 
Effects of  Antibodies against Laminin, Heparan Sulfate 
Proteoglycan, and Monovalent Fragments of  lNO 
on Cranial Neural Crest Migration In Situ 
The monoclonal antibody INO is an IgM, and, therefore has 
numerous functional  binding  sites.  To control  for possible 
effects caused by large antibody molecules that may be un- 
related to functional blockage of the INO epitope, embryos 
were injected with two IgM antibodies, an antibody against 
chick laminin and against a chick heparan sulfate proteogly- 
can. Of the 39 embryos injected with anti-laminin antibod- 
ies, four demonstrated abnormalities in neural crest migra- 
tion,  i.e,,  neural  crest cells within the lumen of the neural 
tube  (see  Table  I).  This  level  of  abnormality  probably 
represents a baseline in the embryos used for this study, since 
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section through the trunk of an embryo injected with INO. The em- 
bryo had 26 somites at the time of injection and the antibody was 
injected at the level of the 17th somite (limb bud region). Both the 
injected side (indicated by the arrow) and the uninjected side had 
similar  patterns  of neural crest  cell distribution  both  within  the 
sclerotome and at the level of the dorsal  aorta (DA). NT, neural 
tube. Bar+ 50 lam. 
injection of concentrated hybridoma medium lacking mono- 
clonal antibodies (referred to as concentrated medium; see 
Materials and Methods)  resulted  in about the same degree 
of embryonic defects (Table I).  However, 90%  of the em- 
bryos were normal (Fig. 6, c and d).  Similarly, injection of 
antibodies against heparan sulfate proteoglycan resulted  in 
abnormalities in only ! of the 28 embryos (Fig. 6, a  and b; 
Table I). 
Since  INO is an IgM and  is  multivalent,  we wished  to 
eliminate the possibility that injected antibody was causing 
its effects by cross-linking. Small fragments of the INO anti- 
body were produced and injected lateral to the mesencephalic 
neural  tube.  Ten embryos were used for injection of small 
IgM fragments (see Table I). 70% of these embryos had de- 
fects that were indistinguishable  from those observed after 
injection of the intact INO IgM molecule (Fig. 4 c). This sug- 
gests that the INO antibody renders its effects by interfering 
with the ability of cells to functionally bind to a  laminin- 
heparan sulfate proteoglycan substrate and not by nonspe- 
cific cross-linking. 
Time Course of  Neural Crest Sensitivity to INO 
For all the experiments described above, embryos ranging in 
age from the neural fold stage to the 9-somite stage were used 
as hosts. Embryos at all these ages exhibited ectopic neural 
crest cells outside of or within the neural tube as well as neu- 
ral tube deformities. In embryos ranging from the neural fold 
to the 9-somite stage, no correlation was found between the 
embryonic stage at the time of injection and the morphology 
of the resultant defects. However, the percentage of affected 
embryos decreased markedly at the 9-somite stage and no ab- 
normalities in neural crest migration were noted in embryos 
having more than 9 somites (n =  18 embryos). Since the anti- 
body distribution and persistence were comparable to those 
of younger embryos, this suggests that embryos are sensitive 
to antibody perturbations for only a limited time during their 
development (Table II). 
Identification of the INO Antigen in Chicken Embryos 
INO is a monoclonal antibody that is thought to recognize 
a  rat  laminin-heparan  sulfate  proteoglycan  complex.  Im- 
munoprecipitations were performed to investigate the nature 
of the 1NO antigen in the chicken embryo. After immunopre- 
cipitation, the antigens were separated on an 8% SDS-poly- 
acrylamide gel and bands were detected  using  silver stain 
(Fig. 7). In 2-d chicken embryos, a major band was detected 
with an approximate molecular mass of 200 kD (Fig. 2, lane 
1). A band of this molecular mass was also detected in im- 
munoprecipitations with the antibody against laminin (2; and 
authors' unpublished observation), suggesting that this may 
represent a  subunit  of laminin.  In addition  to  the  200-kD 
band, two broad smears were detected from 180 to  150 kD 
and from 130 to 85 kD (Fig. 7).  After heparinase digestion 
(Fig. 7, lanes 2 and 3), a band at 200 kD as well as a fainter 
band at 180 kD remained. The broad smears, however, disap- 
peared and numerous low molecular mass bands between 22 
and 44 kD became discernable. These may represent hepa- 
ran  sulfate proteoglycan core  proteins or their breakdown 
products. In all of these preparations, bands were observed 
that probably correspond to known components of the immu- 
noprecipitation procedure including IgMs (70,  25,  22 kD), 
IgGs (55 and 22  kD), and BSA (68 kD)+ 
Discussion 
The data presented  in  this study demonstrate that the INO 
antigen in chick embryos is a  laminin-heparan sulfate pro- 
teoglycan complex that is present along cranial neural crest 
migratory pathways.  In the adult rat,  the  INO antigen  has 
been observed in regions that promote neurite regeneration 
in the peripheral nervous system (10). By microinjecting an- 
tibodies that functionally perturb cell  binding to this com- 
plex, the  present results indicate that the  laminin-heparan 
sulfate proteoglycan complex probably plays a  role  in  the 
normal development of the cranial  neural  crest and neural 
tube. After injection into the mesencephalon, INO antibody 
caused ectopic aggregates of neural crest cells external to the 
neural tube as well as an accumulation of neural crest cells 
within the lumen of the neural tube.  In addition,  many em- 
bryos had neural  tube deformities.  The distributions of the 
INO antigen, laminin, and heparan sulfate proteoglycan are 
all consistent with the idea that INO may either prevent nor- 
mal  migration of some neural  crest cells  from the  neural 
tube, or may affect a subpopulation of already migrating neu- 
ral  cest cells as they  progress through  the  cranial  mesen- 
chyme.  The  LM-HSPG  complex  is  observed  around  the 
basal surface of the neural tube from which neural crest cells 
emigrate as well as in the cranial mesenchyme through which 
they migrate. 
The staining pattern of INO observed in the mesencepha- 
Ion  is  remarkably similar to  that  previously  observed for 
fibronectin (15). Thus, both fibronectin and the LM-HSPG 
complex have temporal and spatial distribution patterns that 
are  consistent  with  playing  a  role  in  cranial  neural  crest 
migration. Previous studies from this laboratory have shown 
that antibodies  against  integrin,  a  fibronectin and  laminin 
The Journal  of Cell Biology, Volume 106, 1988  1326 Figure 6.  Fluorescence photomicrograph of transverse paraffin sections through embryos injected with control antibodies. Neural crest 
cells can be recognized by their immunofluorescence after staining with the HNK-1  antibody.  (a) A  section through the mesencephalon 
of an embryo injected with the antibody against heparan sulfate proteoglycan at the 7-somite stage and fixed  18 h  later. Both injected and 
control sides have identical patterns of neural crest cells distribution, and no ectopic neural crest cells or neural tube (NT) anomalies were 
observed; (b) a section through the rhombencephalon of the embryo picture in a at the level of the forming otic vesicles (OV). (c) A section 
through the anterior rhombencephalon of an embryo injected with the antibody against laminin. This embryo was injected at the 9-somite 
stage and fixed 19 h later. No neural crest or neural tube anomalies were noted. (d) A section through the rhombencephalon of the embryo 
pictured in c illustrating the pattern of neural crest cell distribution at the forming otic vesicles. Bar: (a and d) 50 ~tm; (b) 37 ~m: (c) 47 ~tm. 
Table II.  Temporal Sensitivity of Cranial Neural Crest Cells to INO Injection 
Type of defect 
Embryonic age  Total number  Percent affected  NC in lumen of NT  Ectopic NC cells  Neural tube anomalies 
% 
Neural fold  3  100  67  33  33 
3-Somite  4  100  25  50  75 
4-Somite  4  75  25  75  50 
5-Somite  8  75  25  38  50 
6-Somite  19  68  26  47  32 
7-Somite  6  83  0  67  33 
8-Somite  9  56  44  22  11 
9-Somite  9  33  11  11  22 
10-14-Somites  18  0  0  0  0 
NC, neural crest. NT, neural tube. Percentages are expressed as percent total n of embryos in each category. Some embryos had defects in more than one category. 
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INO antigen.  Lane  1,  2-d  chicken 
embryos  immunoprecipitated  with 
INO without heparinase digestion. A 
strong band was observed at 200 kD 
as well as two broad smears from 180 
to  150 kD and  130 to 85 kD. Lanes 
2 and 3, 2-d (lane 2) and 3-d (lane 
3) chicken embryos immunoprecipi- 
tated with INO and then digested with 
heparinase.  Bands were observed at 
200  kD  and  at  180, but  the  broad 
smear disappeared and numerous tow- 
er molecular mass bands appeared. 
receptor (12),  also inhibit migration of some cranial neural 
crest cells (6, 7). The primary defects caused by integrin anti- 
bodies were a reduction in the numbers of neural crest cells 
on the injected side and a build-up of neural crest cells within 
the lumen of the neural tube. Synthetic peptides that interfere 
with cell binding to fibronectin (4) and antibodies against the 
cell binding region of fibronectin (26) have been reported to 
have similar effects. These experiments sum to suggest an 
important  function  for  fibronectin  in  cranial  neural  crest 
migration. However, antibodies to integrin are equally likely 
to block neural crest cell adhesion to laminin as to fibronec- 
tin. The present study has shown that microinjection of INO, 
which  presumably  blocks  the  interaction  of some  neural 
crest cells with a laminin-heparan sulfate proteoglycan com- 
plex in its native configuration, also perturbs cranial neural 
crest migration. The defects observed after INO injection are 
qualitatively different than those observed after injection of 
antibodies against the integrin receptor or against fibronec- 
tin. The dominant defect with INO was ectopic cells external 
to the neural tube, whereas this defect was not seen in em- 
bryos treated with integrin antibodies. The dominant defect 
with  integrin  antibodies  was  a  reduction  in  neural  crest 
migration, which was absent in INO-treated embryos. Both 
antibodies did, however, result in some embryos with neural 
crest cells within the lumen of the neural tube. One interpre- 
tation of these observations is that laminin-heparan sulfate 
proteoglycan  complex  and  fibronectin  may  play  different 
roles in cranial neural crest migration. For example, different 
subsets  of cells  may  respond  better to  fibronectin  than to 
LM-HSPG. Alternatively, fibronectin and the laminin-hep- 
aran sulfate proteoglycan complex may act at different places 
or times in a complicated cascade of cell-matrix interactions. 
The effects of the INO antibody are qualitatively and quan- 
titatively similar to those previously observed after injection 
of the HNK-1 antibody (9), which recognizes a carbohydrate 
moiety on the surface neural crest cells (33), as well as on 
numerous  cell adhesion  molecules (16).  Microinjection  of 
HNK-I antibody into the mesencephalon resulted in ectopic 
neural crest cells within and external to the neural tube, as 
well as neural tube deformities. In addition, simultaneous in- 
jection of HNK-1 and integrin antibodies resulted in pertur- 
bations that appeared to be additive, suggesting that the two 
molecules act at different sites. Curiously, the HNK-1 anti- 
body alters the adhesion of neural crest cells to laminin but 
not  fibronectin  substrates  in  vitro.  This  may suggest  that 
those HNK-1 antigens on the surface of neural crest cell are 
involved in neural crest cell binding to laminin.  In light of 
this observation, it is interesting to note that the effects of 
INO and HNK-1 antibodies are identical. 
Cranial  neural  crest cells only appear to be sensitive to 
INO during a limited period of their development, i.e. from 
the neural fold stage to the 9-somite stage. In previous studies 
using CSAT (Bronner-Fraser, M., unpublished observation) 
or HNK-1  (9) antibodies,  a  similar time period of cranial 
neural  crest cell sensitivity to injected antibodies was ob- 
served.  This  time period  corresponds  to  the  time during 
which cranial neural crest cells are initially emigrating from 
the neural tube and in the early stages of their migration. It 
is, therefore, possible that INO interferes with either the ini- 
tiation or the early stages of cranial neural crest migration. 
One scenario is that INO may interfere with the departure 
of premigratory neural crest cells from the neural tube. Such 
an interference in emigration could result in cells not con- 
tacting their proper substrate.  This could lead to displaced 
neural crest cells within or adjacent to the neural tube,  or 
presumptive neural crest cells remaining inside and thereby 
deforming the neural  tube.  In our experimental paradigm, 
INO only affects a subpopulation of neural crest cells, since 
many of the cells appear to migrate normally. This could re- 
sult from either inherent differences between populations of 
neural crest cells or from limited temporal interactions be- 
tween neural crest cells and LM-HSPG. 
The finding that INO can block neurite outgrowth in vitro 
(23),  neuronal  regeneration  in  situ  (30),  and  neural  crest 
migration in situ suggests that neurons and neural crest cells 
share some common cell surface receptors and responsive- 
ness to extracellular matrix molecules. The INO antigen is 
present in only the peripheral, but not the central nervous 
system (10). Neural crest cells are progenitors to most of the 
neurons and glia of the peripheral nervous system, with the 
remainder of components arising from the ectodermal pla- 
codes (19). In the trunk,  it has been shown that peripheral 
neurites and neural crest cells share the same migratory path- 
way; both neural  crest cells and motoraxons preferentially 
move through the anterior half of the trunk somites (8,  14, 
27).  Thus,  neural  crest cells and  neurites  may use  similar 
guidance cues.  In adult animals,  the INO antigen has been 
consistently found in regions that support neuronal regenera- 
tion, such as the basal lamina surrounding Schwann cells and 
in the transitional region between the peripheral and the cen- 
tral  nervous  systems (10). The  distribution  of INO during 
embryogenesis is not yet known.  However, the distribution 
of laminin  that  is  likely to occur naturally  within  a  LM- 
HSPG complex suggests that INO is present  in  regions of 
active  neural  crest  cell  migration  and  neurite  outgrowth. 
To date,  functional perturbation of neurite outgrowth  from 
embryonic neurons in  situ has not been reported.  Here no 
abnormalities  in  neural  crest migration or motoraxon out- 
growth were noted when INO was injected into the trunk so- 
mites at similar concentrations to those that resulted in func- 
tional perturbations in the cranial region. This may indicate 
that the guidance cues in the head and in the trunk are differ- 
ent.  Alternatively, it remains possible that higher antibody 
concentrations or different sites or methods of antibody de- 
livery are necessary to achieve functional  perturbations  in 
this region of the embryo. 
The Journal of Cell Biology, Volume  t06,  1988  1328 It has previously been shown that laminin is the active 
component of the  neurite-promoting factors produced  by 
various nonneuronal tissues that are able to support neurite 
outgrowth (18). The form of laminin present in these neurite 
promoting factors is likely to be in the form of a laminin- 
heparan sulfate proteoglycan complex (10, 18, 23),  The pres- 
ent results indicate that this complex is also present in avian 
embryos and is functionally important in some aspects of 
cranial  neural  crest  migration.  The  finding that both  the 
laminin-HSPG complex and fibronectin may play roles in 
neural crest development highlights the fact that multiple in- 
teractions may be important during complicated morphoge- 
netic  events.  It  is  likely that  many  cell  surface  and  cell 
substrate  molecules  are  involved  in  the  guidance of cell 
movement. A goal of future experiments will be to delineate 
the numerous interactions involved in neural crest migration 
and to examine the possible synergism between candidate 
molecules. 
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